SXTPW 60 Degrees Pharmaceuticals, Inc.

Fundamentals / CIK 0001946563 / USD
Other share classes on CIK 0001946563: SXTP

60 Degrees Pharmaceuticals, Inc. reported $907K in revenue and a net loss of $8.35M for the trailing twelve months ended September 30, 2026 (down 46.7% year over year), with a 24.1% gross margin and a -971.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SXTPW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$1.83M$915K$0-$7.52MFY 2022 Revenue: $223KFY 2022 Net Income: -$6.18M2022FY 2023 Revenue: $254KFY 2023 Net Income: -$3.77M2023FY 2024 Revenue: $608KFY 2024 Net Income: -$7.95M2024FY 2025 Revenue: $1.01MFY 2025 Net Income: -$7.37M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.01M $608K $254K $223K
Cost of Revenue $782K $385K $475K $432K
Gross Profit $224K $223K -$221K -$209K
Research & Development $2.11M $4.99M $692K $526K
Total Operating Expenses $8.39M $10.01M $4.93M $1.83M
Operating Income -$7.76M -$9.72M -$5.15M -$1.75M
EBITDA -$7.72M -$9.70M -$5.13M -$1.72M
Interest Expense $7.8K $7.9K $2.29M $3.99M
Income Before Tax -$7.37M -$7.96M -$3.81M -$6.18M
Income Tax Expense $0 $0 $250 $500
Net Income -$7.37M -$7.95M -$3.77M -$6.18M
Basic EPS -$11.73 -$74.17 -$1,183.60 -$37,523.99
Diluted EPS -$11.73 -$74.17 -$1,183.60 -$37,523.99
Basic Shares Outstanding 670.2K 113.7K 3.3K 165
Diluted Shares Outstanding 670.2K 113.7K 3.3K 165

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $233K $208K $162K $303K $438K $101K $164K $242K
Cost of Revenue $331K $151K $86K $121K $538K $50K $73K $118K
Gross Profit -$98K $57K $76K $183K -$100K $51K $90K $124K
Research & Development $783K $599K $281K $717K $786K $232K $371K $614K
Total Operating Expenses $2.43M $2.33M $2.17M $2.11M $2.32M $1.86M $2.09M $2.22M
Operating Income -$2.53M -$2.27M -$2.09M -$1.92M -$2.33M -$1.61M -$1.91M -$2.07M
EBITDA -$2.51M -$2.25M -$2.08M -$1.90M -$2.31M -$1.60M -$1.90M -$2.06M
Interest Expense $1.4K $1.4K $1.4K $3.1K $1.7K $1.2K $1.8K $1.4K
Income Before Tax -$2.56M -$2.27M -$2.09M -$1.44M -$2.32M -$1.73M -$1.88M -$2.05M
Income Tax Expense -- -- -- -$1.8K $250 $1.5K $63 -$751
Net Income -$2.56M -$2.26M -$2.09M -$1.44M -$2.32M -$1.73M -$1.88M -$2.05M
Basic EPS -$0.75 -$0.90 -$1.28 -- -$2.66 -$5.01 -$6.25 --
Diluted EPS -$0.75 -$0.90 -$1.28 -- -$2.66 -$5.01 -$6.25 --
Basic Shares Outstanding 3.6M 2.7M 1.7M -- 918.9K 368.2K 320.9K --
Diluted Shares Outstanding 3.6M 2.7M 1.7M -- 918.9K 368.2K 320.9K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.51M $1.66M $2.14M $265K
Short-Term Investments $1.24M $1.73M -- --
Cash & Short-Term Investments $2.75M $3.39M $2.14M $265K
Accounts Receivable, Net $510K $487K $231K $46K
Inventory $657K $443K $466K $519K
Total Current Assets $4.90M $5.39M $7.24M $1.10M
Property, Plant & Equipment, Net $246K $150K $58K $21K
Intangible Assets $224K $157K $227K $164K
Other Non-Current Assets $224K $223K $483K --
Total Non-Current Assets $471K $373K $541K $198K
Total Assets $5.37M $5.76M $7.78M $1.30M
Accounts Payable $668K -- -- --
Short-Term Debt $12K $8.8K $8.8K --
Total Current Liabilities $1.85M $1.66M $2.84M $23.92M
Long-Term Debt $144K $147K $141K $16.86M
Total Non-Current Liabilities $141K $147K $150K $1.53M
Total Liabilities $1.99M $1.80M $2.99M $25.45M
Total Debt (incl. Leases) $156K $156K $164K $16.87M
Common Stock $116 $14 $10 $239
Retained Earnings -$47.89M -$40.53M -$32.58M -$28.82M
Accumulated Other Comp. Income $143K $135K $136K $74K
Total Stockholders' Equity $3.46M $4.04M $4.87M -$23.58M
Total Equity $3.38M $3.96M $4.80M -$24.15M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $306K $1.02M $3.34M $1.51M $4.12M $1.97M $3.45M $1.66M
Short-Term Investments -- -- -- $1.24M $0 $0 -- $1.73M
Cash & Short-Term Investments $306K $1.02M $3.34M $2.75M $4.12M $1.97M $3.45M $3.39M
Accounts Receivable, Net $338K $567K $336K $510K $674K $295K $488K $487K
Inventory $579K $878K $911K $657K $527K $799K $773K $443K
Total Current Assets $2.56M $3.73M $6.26M $4.90M $6.31M $3.84M $5.65M $5.39M
Property, Plant & Equipment, Net $226K $243K $260K $246K $228K $194K $156K $150K
Intangible Assets $304K $309K $243K $224K $152K $144K $150K $157K
Other Non-Current Assets $304K $309K $243K $224K $152K $144K $172K $223K
Total Non-Current Assets $530K $551K $503K $471K $380K $338K $328K $373K
Total Assets $3.09M $4.28M $6.76M $5.37M $6.69M $4.18M $5.98M $5.76M
Accounts Payable $1.15M -- -- $668K -- -- -- --
Short-Term Debt $3.6K $2.0K $8.8K $12K $8.8K $8.8K $8.8K $8.8K
Total Current Liabilities $2.19M $1.61M $1.88M $1.85M $2.20M $1.69M $1.80M $1.66M
Long-Term Debt $146K $148K $141K $144K $141K $141K $141K $147K
Total Non-Current Liabilities $147K $149K $143K $141K $145K $145K $147K $147K
Total Liabilities $2.34M $1.75M $2.02M $1.99M $2.34M $1.84M $1.95M $1.80M
Total Debt (incl. Leases) $150K $150K $150K $156K $150K $150K $150K $156K
Common Stock $390 $264 $264 $116 $410 $147 $147 $14
Retained Earnings -$54.80M -$52.25M -$49.98M -$47.89M -$46.45M -$44.14M -$42.40M -$40.53M
Accumulated Other Comp. Income $154K $151K $149K $143K $144K $143K $126K $135K
Total Stockholders' Equity $842K $2.61M $4.83M $3.46M $4.43M $2.43M $4.11M $4.04M
Total Equity $756K $2.53M $4.74M $3.38M $4.35M $2.35M $4.03M $3.96M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$7.37M -$7.96M -$3.81M -$6.18M
Depreciation & Amortization $43K $12K $21K $33K
Stock-Based Compensation $456K $3.61M $213K $0
Change in Receivables -$23K -$255K -$185K $100K
Change in Inventory -$466K $23K $213K $10K
Operating Cash Flow -$6.85M -$5.65M -$4.54M -$1.01M
Capital Expenditure -$140K -$104K -$58K --
Free Cash Flow -$6.99M -$5.75M -$4.60M --
Investing Cash Flow $255K -$1.89M -$116K -$60K
Common Stock Issued -- -- $1.05M $1.05M
Financing Cash Flow $6.44M $7.05M $6.47M $1.22M
Net Change in Cash -$149K -$483K $1.88M $149K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.56M -$2.27M -$2.09M -$1.44M -$2.32M -$1.73M -$1.88M -$2.05M
Depreciation & Amortization $17K $17K $17K $15K $12K $9.2K $6.7K $5.4K
Stock-Based Compensation $48K $98K $124K $112K $79K $79K $187K $62K
Change in Receivables $229K -$231K $174K $164K -$379K $193K -$1.5K -$163K
Change in Inventory -$204K $33K -$2.0K -$137K $28K -$26K -$330K $9.3K
Operating Cash Flow -$1.45M -$2.23M -$2.74M -$1.69M -$2.11M -$1.45M -$1.60M -$1.64M
Capital Expenditure $0 $0 -$30K -$80K -$10.0K -$47K -$2.7K --
Free Cash Flow -$1.45M -$2.23M -$2.77M -$1.77M -$2.12M -$1.50M -$1.60M --
Investing Cash Flow -$13K -$86K $1.19M -$1.37M -$25K -$52K $1.70M -$2.1K
Financing Cash Flow $740K $0 $3.37M $459K $4.28M $0 $1.70M $973
Net Change in Cash -$716K -$2.32M $1.83M -$2.61M $2.15M -$1.48M $1.79M -$1.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 22.3% 36.7% -87.1% -93.7%
Operating Margin -771.6% -1599.0% -2032.8% -784.2%
Net Profit Margin -732.5% -1308.0% -1485.1% -2769.5%
Return on Equity (ROE) -212.7% -196.9% -77.3% --
Return on Assets (ROA) -137.3% -138.0% -48.4% -476.5%
Current Ratio 2.65x 3.25x 2.55x 0.05x
Quick Ratio 2.30x 2.98x 2.39x 0.02x
Debt to Equity 0.04x 0.04x 0.03x --
Revenue Growth (YoY) +65.5% +139.6% +13.6% --
Gross Profit Growth (YoY) +0.4% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 24.1% 19.4% 20.9% 22.3% 17.4% 45.0% 41.0% 36.7%
Operating Margin -971.7% -774.8% -791.1% -771.6% -838.0% -1200.7% -1545.4% -1599.0%
Net Profit Margin -921.0% -729.9% -754.8% -732.5% -844.7% -1218.4% -1540.9% -1308.0%
Return on Equity (ROE) -991.6% -310.2% -156.9% -212.7% -179.9% -321.8% -249.5% -196.9%
Return on Assets (ROA) -269.9% -189.3% -112.0% -137.3% -119.2% -186.9% -171.5% -138.0%
Current Ratio 1.17x 2.32x 3.34x 2.65x 2.87x 2.27x 3.13x 3.25x
Quick Ratio 0.91x 1.78x 2.85x 2.30x 2.63x 1.80x 2.71x 2.98x
Debt to Equity 0.18x 0.06x 0.03x 0.04x 0.03x 0.06x 0.04x 0.04x
Revenue Growth (YoY) -46.7% +106.0% -0.9% +25.6% +223.4% -19.2% +54.8% +92.3%
Gross Profit Growth (YoY) -- +11.6% -15.4% +47.9% -524.0% +43.7% +124.4% --
Net Income Growth (YoY) -- -- -- -- -- -- -535.9% --
EPS Growth (YoY) -- -- -- -- -- -- -117.1% --
Source: SEC EDGAR CompanyFacts (CIK 0001946563) · from March 31, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal